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The presence of extended-spectrum beta-lactamase-producing Escherichia coli in food animals is a public health 
concern. The aim of this study was to phenotypically detect the extended β-lactamase and AmpC β-lactamase-producing 
E. coli isolated from pig caecum from three slaughterhouses in the North-East of Romania. After collecting the cecal 
samples, they were phenotypically processed. ESBL and AmpC screening was carried out by cultivation on MacConkey 
medium with addition of cefotaxime (MC+CTX). The isolates were confirmed as being E. coli based on the biochemical 
properties using MIU, TSI and API 20E and as ESBL based on synergy tests between clavulanic acid and ceftazidime 
and/or clavulanic acid and cefotaxime.   Phenotypical detection of AmpC beta-lactamase-producing strains was carried 
out through a stable AmpC cephalosporin (cefepime). Following ESBL/AmpC screening, out of the 128 analysed 
samples, 51 (39.84%) grew on MC+CTX and they were identified as E. coli. After performing microdilution in broth 
using EUVSEC2 plates, 78.43% isolates were identified with ESBL phenotype, 9.8% isolates with ESBL/AmpC 
phenotype, and 11.77% isolates with AmpC phenotype. In this study, although a limited number of strains were 
analysed, the obtained results phenotypically confirm the presence of ESBL and AmpC enzymes in slaughtered pig 
populations from the North-East of Romania. 
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INTRODUCTION 
Extended-spectrum beta-lactamase (ESBL) enzyme and AmpC beta-lactamase 
enzyme-producing Enterobacteriaceae strains represent a major public health concern 
as a result of the resistance to third-generation cephalosporins, antibiotics that are 
commonly used both in human and in veterinary medicine (Salviati et al., 2014). The 
carriage of ESBL and AmpC enzymes and the risk of their transmission from 
production animals to humans through various routes (direct contact, contaminated 
food) is known and signalled in the scientific literature (Kola et al., 2012; Dahms et al., 
2015). Several studies from Europe revealed the association of consumption of 
cephalosporins in pig farms with the high prevalence of ESBL-producing E. coli 
isolates (Hammerum et al., 2014; Dahms et al., 2015; Schmithausen et al., 2015). 
The aim of the study was to assess the current situation regarding the faecal carriage 







MATERIALS AND METHODS 
Isolation of ESBL/AmpC-producing Escherichia coli strains from the samples of swine caecal content was carried out 
according to the European Reference Laboratory for Antimicrobial Resistance (EURL-AR) (Hasman et al., 2018). After 
sterile collection of caecal content, a pre-enrichment was carried out first using peptone water. The ESBL/AmpC screening 
was performed using the selective MacConkey medium (Oxoid, Basingstoke, UK), with the addition of cefotaxime. All 
colonies with morphology typical for Escherichia coli were confirmed based on the biochemical properties using the triple-
sugar-iron (TSI) agar test, the motility-indole-urea (MIU) medium or Api 20E for atypical E. coli strains. For phenotypical 
confirmation of ESBL isolates, the microdilution method was carried out in broth using EUVSEC2 plates that contain 
cefoxitine, cefepime, cefotaxime, ceftazidime and clavulanate combined with cefotaxime and ceftazidime. The results were 
interpreted based on the synergy tests between clavulanic acid and ceftazidime and/or clavulanic acid and cefotaxime. 
Phenotypical detection of AmpC beta-lactamase-producing strains was carried out through a stable AmpC cephalosporin: 
cefepime. 
 
RESULTS AND DISCUSSIONS    
A total of 128 samples of caecal content were analysed of which, following ESBL/AmpC screening, 51 (39.84%) 
presumptive extended-spectrum beta-lactamase enzyme-producing and/or AmpC enzyme-producing E. coli strains have 
been isolated and identified. The synergy test between the potentiated cephalosporin and the simple cephalosporin 
phenotypically confirmed that 100% of the E. coli isolates identified following screening are presumptive ESBL and/or 
AmpC-producing isolates. Also, following centralization of the results obtained from the 51 E. coli isolates of animal 
origin, attained following ESBL/AmpC screening, most of them showed ESBL phenotype (40/51; 78.43%), 5/51 (9.80%) 
showed ESBL+AmpC phenotype, and 6/51 (11.77%) showed AmpC phenotype (Table 1). 
Table 1. Phenotypes identified in E. coli isolates 
Source of E. coli 
strains isolated on 
MC+CTX† 
No. of strains 
isolated on 
MC+CTX* 
Type of phenotype 
No. of E. coli strains 
phenotype ESBL 
(2016+2017) 




No. of E. coli strains 
phenotype AmpC 
(2016+2017) 
IS† slaughterhouse 6 5 1 0 
BT†slaughterhouse 32 26 3 3 
SV† slaughterhouse 13 9 1 3 
Total isolates of 
animal origin 
51 40 5 6 
MC+CTX† - MacConkey medium with the addition of cefotaxime; IS† - Iași; BT† - Botoșani; SV† - Suceava 
For swine, the faecal carriage with ESBL enzyme-producing E. coli strains has big geographic differences, with 
proportions that vary between 15.2% in Switzerland (faecal samples) and 23.4% in the United Kingdom (caecal samples) 
or 49% in Portugal (faecal samples) (Geser et al., 2011; Ramos et al., 2013; Randall et al., 2014). Furthermore, in Belgium, 
the study carried out by Van Damme et al. (Van Damme et al., 2017) highlighted the presence of positive ESBL/AmpC E. 
coli strains in 75% of the samples of faecal batches and 47% of the samples of tonsils collected upon slaughtering of pigs. 
The preliminary results from this study fall into the range listed in other similar studies carried out in Europe. Moreover, 
the big differences between various areas of Europe can be justified by the policy of each country on the administration of 
antibiotics in production animals. In some countries, such as the Netherlands, following a high prevalence obtained, starting 
January 2013, veterinarians have been legally forced to limit the use of third/fourth-generation cephalosporins and 
fluoroquinolones only in infections confirmed by bacteriological examinations and susceptibility tests (SDa, 2013). 
Considering that pigs and, subsequently, pork add to the zoonotic spread of ESBL/AmpC E. coli strains (Carmo et al., 
2014; Evers et al., 2017; Lazarus et al., 2015) and that ESBL/AmpC strains can persist in the human gastrointestinal track 
for up to 5 years (Brolund, 2014), intervention strategies are necessary to reduce the presence of these isolates on pig 
carcasses and to reduce the exposure of humans to ESBL/AmpC-producing enterobacteria. 
 
CONCLUSIONS 
In conclusion, the high percentage (39.84%) of presumptive extended-spectrum beta-lactamase enzyme-producing 
and/or AmpC enzyme-producing E. coli strains isolated from the caecum of slaughtered pigs can represent an important 
source of contamination of carcasses and pork, respectively, and there is a risk of their transmission from production 
animals to humans through various routes. 
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